Home/Filings/4/0001415889-24-023226
4//SEC Filing

Dunn Michael J. 4

Accession 0001415889-24-023226

CIK 0001534133other

Filed

Sep 10, 8:00 PM ET

Accepted

Sep 11, 5:00 PM ET

Size

8.0 KB

Accession

0001415889-24-023226

Insider Transaction Report

Form 4
Period: 2024-09-09
Dunn Michael J.
President and COO
Transactions
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2024-09-0911,7610 total
    Exercise: $1.39Exp: 2024-10-01Common Stock (11,761 underlying)
  • Exercise/Conversion

    Common Stock

    2024-09-09$1.39/sh+11,761$16,34811,761 total
Footnotes (2)
  • [F1]Immediately exercisable.
  • [F2]Received in exchange for a stock option to acquire 408,402 shares of common stock of CalciMedica, Inc. ("CalciMedica") pursuant to an Agreement and Plan of Merger and Reorganization (the "Merger Agreement") by and among CalciMedica, the Issuer (formerly known as Graybug Vision, Inc.) and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer ("Merger Sub"). Under the terms of the Merger Agreement, on March 20, 2023, Merger Sub merged with and into CalciMedica (the "Merger"), with CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc.

Issuer

CalciMedica, Inc.

CIK 0001534133

Entity typeother

Related Parties

1
  • filerCIK 0001968792

Filing Metadata

Form type
4
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 5:00 PM ET
Size
8.0 KB